Navigation Links
Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug

can be life-threatening if not treated.

Oropharyngeal candidiasis, also referred to as "thrush", is a local infection seen in patients treated with antibiotics or steroids, chemotherapy, or radiation therapy to the head and neck, and those with cellular immune deficiency states, such as HIV and AIDS. Patients with xerostomia and those treated with inhaled corticosteroids for asthma or rhinitis are also at risk. Oropharyngeal candidiasis infection can cause great discomfort, and if not treated, can spread from the primary site of infection through the blood stream to cause a disseminated infection. Disseminated fungal infections are associated with a high mortality rate.

The demand for effective anti-fungals is driven by a rising incidence of immunocompromised patients populations including individuals with HIV, cancer, asthma and diabetes, among others. In 2004, global sales of topical anti-fungal drugs represented nearly a US $1.6 billion dollar market, and it is projected to grow to US $2.1 billion by 2009. Pacgen estimates that the current worldwide market opportunity for a novel, safe and effective, oral candidiasis therapy is approximately US $300 million.

About Pacgen

Pacgen is a life sciences company focused on the development of therapeutics for the treatment of infectious and inflammatory diseases. The Company's lead product, PAC-113, is an anti-fungal in a Phase II clinical program. Pacgen also has candidates in an early stage research program. The most advanced of these candidates is a protein therapeutic, PAC-G31P, which is currently being investigated in preclinical studies for its potential to treat inflammatory diseases such as acute respiratory distress syndrome. For additional information, please visit www.pacgenbiopharm.com.

    NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS

    RELEASE. THE TSX VENTURE EXHANGE DOES NOT ACCE
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, ... (OTCQX: DMPI) (DelMar and the Company), a company ... in new orphan drug indications, today announced that ... U.S. Patent and Trademark Office (USPTO) for patent ... to improve the therapeutic benefit of suboptimally administered ...
(Date:3/2/2015)... Ohio , March 2, 2015  Sarnova, ... the launch of the new www.tri-anim.com ... full-service, specialty healthcare distributor of respiratory, anesthesia and ... country. The site has many ... overall experience, making online shopping and ordering easier ...
(Date:3/2/2015)... , March 2, 2015  Maquet Medical Systems ... it has signed an exclusive distribution agreement with ... flagship product, the Flight 60 mechanical ventilator. The ... providing dependable and affordable mobility. Starting in the ... be sold in the United States ...
Breaking Medicine Technology:DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3
... Midwest college that is producing alumni with sizeable reputations in ... Lilly Endowment to launch a School of Pharmacy. ... Laureate in chemistry, the inventor of Teflon®, the discoverer of ... of the U.S. Food and Drug Administration among its graduates. ...
... 20, 2010 Varian Medical Systems (NYSE: VAR ... quarter of fiscal year 2011 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ...
Cached Medicine Technology:Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 2Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 3Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call 2
(Date:3/2/2015)... York (PRWEB) March 02, 2015 Tyrone ... Idoll Magazine, a medium for the model agency industry, ... find, and buy Mango, Passion Fruit, Pink Grapefruit, Pomegranate, ... 3rd, 2015, after 1pm. , At a cost of ... recently came under fire by announcing the brands commitment ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction ... Construction Week (March 1-7, sponsored by the National Association ... History Month, Robins & Morton is recognizing several women ... the construction industry as a whole. From the craft ... roles in between, each woman has a story to ...
(Date:3/2/2015)... Va. (PRWEB) March 02, 2015 The ... nonprofit authority on the use of health IT to ... white paper, “ICD-10 Testing for Small Providers.” The white ... with a starting point for ICD-10 testing by focusing ... payers to ensure compliance with the October 1, 2015 ...
(Date:3/2/2015)... NEW YORK, NY (PRWEB) March 02, 2015 ... kicks off March 2–8 and will provide opportunities for people ... find new ways to help people with MS live their ... recognize progress made and to inspire others to join the ... , Multiple sclerosis, an unpredictable, often disabling disease of the ...
(Date:3/2/2015)... March 02, 2015 Four Seasons Resort Maui ... its 25th anniversary this year, having officially opened its doors ... luxury resort is honoring over 70 employees who started on ... from amongst the approximately 400 original employees. The celebration ... Oceanfront Lawn. , This Four Seasons flagship resort, ...
Breaking Medicine News(10 mins):Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... 20 EmPower Research, LLC, a pioneer in,the ... its,first-ever study on the Indian Contract Research Organization ... Contract Research Industry, (CRO-nicles),captures the industry,s current position, ... top line industry executives first hand. India ...
... SAN DIEGO, Oct. 19 Local youth teamed up ... the San Diego,County Alcohol Policy Panel,s annual Legislative Forum ... as distilled spirits and to,investigate the labeling practices of ... enforcement officers and teachers energy drinks, some,with alcohol some ...
... WASHINGTON, Oct. 19 Following is a statement,by ... Healthcare Products,Association (CHPA), regarding the recommendations issued today ... Advisory Committee and,Pediatric Advisory Committee. At a meeting ... over-the-counter cough and cold medicines in children., ...
... Tablets are specially formulated ... for children, ... the safety and efficacy of many name brand,over-the-counter children,s cough and cold ... of their children,s cold and flu,symptoms. Hyland,s, Inc. is pleased to ...
... to State Supreme Court, WILMINGTON, Del., Oct. 19 ... in the Spelter, W.Va., zinc,smelter class action lawsuit. The ... J. Mobley. "We are extremely disappointed by the ... it has been unfairly punished for doing,the right thing ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... registration statement with the Securities,and Exchange Commission relating to ... stock. In connection with this offering,Arena plans to grant ... to,an additional 1,500,000 shares of common stock to cover ...
Cached Medicine News:Health News:EmPower Research Launches Indian CRO Industry Report 2Health News:Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:Hyland's Homeopathic Medicine Offers Parents Safe, All-Natural Option to Alleviate the Symptoms of Colds 2Health News:DuPont Responds to Spelter, W.Va., Lawsuit Decision 2Health News:Arena Pharmaceuticals Announces Public Offering of Common Stock 2
Straight shafts with two point fixation. Tips separated by 3 mm, each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with dull finish....
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....
Narrow 12 mm jaws with fine teeth. Serrated handle with polished finish....
Medicine Products: